In the update at the end of June it was stated that DIPG interim data was due out in July/August. Not reporting such a close term data point demonstrates a total lack of control and management. The data in DIPG will point the path to an NDA and PRV. it is critical for patients that the Co is sold. Someone will pick up a bargain, due to management's negligent performance. They state they have 11 pax trials open and evt is in dose escalation and they find zero to talk about in 3 months!!! Dr. Friend et al. be a friend to patients and long suffering share holders and don't dream of suddenly being a competent CEO, negotiate once on any take over offer then sell! Please then go work at Walmart as a front door host, learn something about basic communication skills.
KZA Price at posting:
15.5¢ Sentiment: Hold Disclosure: Held
